BDR Pharma targeting 2027 for IPO launch, looking to acquire units in US, says CMD Dharmesh Shah

featured-image

In the past few years, BDR Pharma has spent close to Rs 600 crore and plans to invest another Rs 700 crore to boost growth and acquisitions over the next three years.